Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Bone SPECT superior to FDG PET for detecting bone metastases
April 28th, 2005
Bone single photon emission computed tomography (SPECT) is better than fluorodeoxyglucose positron emission tomography (FDG PET) for detecting breast cancer that has spread (metastasized) to a patient's bones, according to researchers from Shizuoka Cancer Center Hospital in Japan. FDG PET is an imaging technique based on the increased metabolism of glucose in tumor cells. SPECT is a type of nuclear medicine scan that detects special radioactive elements administered to the patient by the physician. According to the authors, due to these differences in method, bone SPECT images can reveal the location of bone metastases, whereas PET cannot. In addition, bone SPECT can...
Source: Women's Health Weekly (2005-04-28)
|
